Revolutionizing GERD diagnosis: how capsule sponge testing prioritizes high-risk patients while easing the strain on endoscopy services. Study: Clinical application of capsule sponge testing in ...

Please provide your email address to receive an email when new articles are posted on . A capsule-sponge test may help risk-stratify patients with Barrett’s esophagus. Patients classified as low risk ...

Endoscopies could be replaced by far less invasive capsule sponge tests for half of all patients with Barrett's esophagus, a known precursor to esophageal cancer, according to a new study from ...

Capsule sponge-based surveillance could be used in lieu of endoscopy for low-risk Barrett esophagus (BE) surveillance, a prospective multisite UK study found. The biomarker risk panel collected by the ...

Endoscopies could be replaced by far less invasive capsule sponge tests for half of all patients with Barrett's esophagus, a known precursor to esophageal cancer, according to a new study by ...

The researchers found that in the high-risk patient group, the positive predictive value for any dysplasia or worse was 37.7%. HealthDay News — In adult patients with nondysplastic Barrett esophagus ...

Barrett’s oesophagus is associated with an approximately tenfold increase in the risk of oesophageal cancer compared with the ...

Cyted Ltd. received U.S. FDA 510(k) clearance for its Endosign capsule technology, a non-endoscopic capsule sponge device used to collect pan-esophageal samples to detect esophageal pre-cancer and ...

The study has been hailed as the ‘pinnacle of many years of painstaking research’ by experts. Sign up for the top news stories every day to keep you informed with what's going on in the West Midlands.

Endoscopies could be replaced by far less invasive capsule sponge tests for half of all patients with Barrett’s oesophagus, a known precursor to oesophageal cancer, according to a new study from ...